# OCTAVE Capital

> OCTAVE Capital is a VC fund in Singapore backing Health Care and Education. See 33 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 33
- Last investment: Dec 2025
- Lead investor: 52%
- Last fund: Mar 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/heritas-capital/
- Website: https://www.heritascapital.com/

OCTAVE Capital is a VC fund in Singapore focused on Health Care and Education. Heritas Capital operates as a private equity and venture capital investment firm.

## Contacts

5 contacts available for OCTAVE Capital. Shizune tracks 3 team members at OCTAVE Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/heritas-capital-management?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $4k–$9.8M |
| Series A | $3M–$126M |
| Series B | $10M–$45M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 27% |
| Education | 5 | 15% |
| Wellness | 4 | 12% |
| E-Learning | 3 | 9% |
| Biotechnology | 3 | 9% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 9 | 27% |
| Seed | 7 | 21% |
| Series B | 4 | 12% |
| Series C | 4 | 12% |
| Venture - Series Unknown | 3 | 9% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 7 | 21% |
| India | 3 | 9% |
| Indonesia | 3 | 9% |
| United States | 2 | 6% |
| Spain | 1 | 3% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chik Wai Chiew | CEO & Executive Director | 0 | https://shizune.co/investors/profile/chik-wai-chiew-11da |
| Chik Wai Chiew | CEO & Executive Director | 10 | https://shizune.co/investors/profile/chik-wai-chiew |
| Sin-Hong Leong | SVP ,COO , Head of Compliance & Risk Management | 0 | https://shizune.co/investors/profile/sin-hong-leong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| bound4blue | bound4blue developes foldable and autonomous wingsail system to be integrated onto a wide range of vessels.The system has been conceived as a complementary propulsion system, which produces effective thrust from existing winds, reducing the main engine power required and, therefore, delivering fuel consumption and pollutant emissions reductionsof up to 40% and it ensures a payback period under 5 years. | $44M |  | Dec 09, 2025 |  |
| Kreedo Early Childhood Solutions | Kreedo provides a complete preschool solution. | $4M | Series A | Aug 27, 2024 |  |
| The Gentle Group | SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems. | $2M | Venture - Series Unknown | Jul 08, 2024 |  |
| ConveGenius | ConveGenius is focused on nurturing and harnessing value by providing affordable educational solutions to create impact in large volumes. Their core competence lies in building mobile products/ apps/ games catered for global and local markets likewise. The company is focussed towards providing quality education to children at risk byintegrating technology with education and working with state governments to penetrate the rural and semi urban areas of India. It also aims to cater to the global urban market using retailing and e-tailing channels for its various world-class high-end educational solutions. ConveGenius is based out of India and Singapore. Their India office is headquartered in Noida. | $7M | Series A | Jan 11, 2024 |  |
| Bettr Group | Bettr Group is a coffee company that wholesales and retails coffee bars and equipment. | $1.5M | Seed | Oct 13, 2023 |  |
| Cakap | Cakap is an upskilling platform that enables 2-way learning interactions between students and professional teachers. Cakap is an application that enables a 2-way interaction between life-skill learners and professional tutors around the Asia Pacific via video call and text conversation. CAKAP delivers high-quality education that is accessible,acceptable, affordable for people. and will be able to elevate people’s lives by enabling skill enhancement for everyone, from anywhere, at any time. | $7.5M | Series C | Apr 12, 2023 |  |
| Cakap | Cakap is an upskilling platform that enables 2-way learning interactions between students and professional teachers. Cakap is an application that enables a 2-way interaction between life-skill learners and professional tutors around the Asia Pacific via video call and text conversation. CAKAP delivers high-quality education that is accessible,acceptable, affordable for people. and will be able to elevate people’s lives by enabling skill enhancement for everyone, from anywhere, at any time. | $7.5M | Series C | Apr 12, 2023 |  |
| Holmusk | Holmusk is developing a Real-World Evidence platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. It works by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that can be used to maketreatment decisions, as well as the commercialization of new drugs.Holmusk was founded in 2015 and is based in Singapore, Malaysia, and the USA. | $45M | Series B | Jan 09, 2023 |  |
| Alchemy Foodtech | Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes.The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtechprovides diabetics with far better disease management and also the general public with diabetes prevention. | $3M | Convertible Note | Dec 22, 2022 |  |
| Tessa Therapeutics | Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors. The company's therapy specializes in developing virus specific T-cells and CAR T cells for the treatment of lymphoma, enabling healthcare providers to treat cancer patients and improve their lives. | $126M | Series A | Jun 09, 2022 |  |

10 of 33 investments shown.

## Co-investors
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund, 10 deals together
- [BEENEXT](https://shizune.co/investors/profile/bee-next) — VC Fund, 3 deals together
- [Bits x Bites](https://shizune.co/investors/profile/bits-x-bites) — VC Fund, 3 deals together
- [Health Catalyst Capital](https://shizune.co/investors/profile/health-catalyst-capital) — VC Fund, 3 deals together
- [MDI Ventures](https://shizune.co/investors/profile/mdi-ventures) — VC Fund, 3 deals together
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Health Care Investors in Singapore](https://shizune.co/investors/health-care-investors-singapore)
- [Health Care VC Funds in Singapore](https://shizune.co/investors/health-care-vc-funds-singapore)
- [Food and Beverage Investors in Singapore](https://shizune.co/investors/food-and-beverage-investors-singapore)
- [Food and Beverage VC Funds in Singapore](https://shizune.co/investors/food-and-beverage-vc-funds-singapore)
- [Gaming Investors in Singapore](https://shizune.co/investors/gaming-investors-singapore)
- [Gaming VC Funds in Singapore](https://shizune.co/investors/gaming-vc-funds-singapore)

## FAQ

### What does OCTAVE Capital invest in?

OCTAVE Capital invests primarily in Health Care, Education and Wellness startups, most often at Series A and Seed stage. Most of the 33 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is OCTAVE Capital's check size?

OCTAVE Capital typically joins rounds of $4k–$9.8M at Seed, $3M–$126M at Series A and $10M–$45M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds OCTAVE Capital participates in.

### How do I contact OCTAVE Capital?

Public channels for OCTAVE Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at OCTAVE Capital?

The team at OCTAVE Capital includes Chik Wai Chiew (CEO & Executive Director), Chik Wai Chiew (CEO & Executive Director) and Sin-Hong Leong (SVP ,COO , Head of Compliance & Risk Management). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co